You can buy or sell CHF Solutions and other stocks, options, ETFs, and crypto commission-free!
CHF Solutions, Inc. Common Stock, also called CHF Solutions, is a medical device company, which engages in the provision of products for the treatment of fluid overload. Read More Its product include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
Eden Prairie, Minnesota
52 Week High
52 Week Low
Stock Price, News, & Analysis for CHF Solutions
CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It offers Aquadex FlexFlow consoles and the rel...
Seeking AlphaFeb 20
CHF Solutions, Inc. (CHFS) CEO John Erb on Q4 2018 Results - Earnings Call Transcript
CHF Solutions, Inc. (NASDAQ:CHFS) Q4 2018 Earnings Conference Call February 20, 2019 9:00 AM ET Company Participants Scott Gordon - President of CORE IR John Erb - Chief Executive Officer and President, Chairman of the Board Claudia Drayton - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Good morning and welcome to the CHF Solutions’ Earnings Conference Call for the Fourth Quarter ending December 31, 2018. All participants will be in listen-only mod...
Expected May 7, Pre-Market